102
Participants
Start Date
June 1, 2020
Primary Completion Date
June 30, 2025
Study Completion Date
December 31, 2025
gemcitabine and oxaliplatin.
GEMOX Conventional chemotherapy:gemcitabine and oxaliplatin.
Afatinib
Target therapy Drug: afatinib
RECRUITING
Renji hospital, Shanghai Jiaotong University School of Medicine, Shanghai
RECRUITING
Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai
Shanghai Zhongshan Hospital
OTHER
Ruijin Hospital
OTHER
RenJi Hospital
OTHER
Qilu Hospital of Shandong University
OTHER
The First Affiliated Hospital of Anhui Medical University
OTHER
Shanghai East Hospital of Tongji University
OTHER
Changshu Affiliated Hospital of Soochow University
OTHER
Qinghai People's Hospital
OTHER
The Second People's Hospital of Baoshan, Yunnan Province
UNKNOWN
Lanzhou University Second Hospital
OTHER
The Affiliated Hospital of Inner Mongolia Medical University
OTHER
The First People's Hospital of Nantong
UNKNOWN
Shanghai Jiao Tong University School of Medicine
OTHER